Plasma Ketone and Medium Chain Fatty Acid Response in Humans Consuming Different Medium Chain Triglycerides During a Metabolic Study Day

Background: Medium chain triglycerides (MCT) are ketogenic but the relationship between the change in plasma ketones and the change plasma medium chain fatty acids (MCFA)—octanoate, decanoate, or dodecanoate—after an oral dose of MCT is not well-known. An 8 h metabolic study day is a suitable model to assess the acute effects on plasma ketones and MCFA after a dose of tricaprylin (C8), tricaprin (C10), trilaurin (C12) or mixed MCT (C8C10). Objective: To assess in healthy humans the relationship between the change in plasma ketones, and octanoate, decanoate and dodecanoate in plasma total lipids during an 8 h metabolic study day in which a first 20 ml dose of the homogenized test oil is taken with breakfast and a second 20 ml dose is taken 4 h later without an accompanying meal. Results: The change in plasma acetoacetate, β-hydroxybutyrate and total ketones was highest after C8 (0.5 to 3 h post-dose) and was lower during tests in which octanoate was absent or was diluted by C10 in the test oil. The plasma ketone response was also about 2 fold higher without an accompanying meal (P = 0.012). However, except during the pure C10 test, the response of octanoate, decanoate or dodecanoate in plasma total lipids to the test oils was not affected by consuming an accompanying meal. Except with C12, the 4 h area-under-the-curve of plasma β-hydroxybutyrate/acetoacetate was 2–3 fold higher when no meal was consumed (P < 0.04). Conclusion: C8 was about three times more ketogenic than C10 and about six times more ketogenic than C12 under these acute metabolic test conditions, an effect related to the post-dose increase in octanoate in plasma total lipids.

[1]  H. Kunugi,et al.  Lauric acid promotes neuronal maturation mediated by astrocytes in primary cortical cultures , 2020, Heliyon.

[2]  B. Puri,et al.  Induced Ketosis as a Treatment for Neuroprogressive Disorders: Food for Thought? , 2020, The international journal of neuropsychopharmacology.

[3]  B. Cuenoud,et al.  Medium Chain Triglycerides Modulate the Ketogenic Effect of a Metabolic Switch , 2020, Frontiers in Nutrition.

[4]  A. Heiser,et al.  Metabolic and Immunological Effects of Intermittent Fasting on a Ketogenic Diet Containing Medium-Chain Triglycerides in Healthy Dogs , 2020, Frontiers in Veterinary Science.

[5]  R. Gruetter,et al.  Nutritional Ketosis Increases NAD+/NADH Ratio in Healthy Human Brain: An in Vivo Study by 31P-MRS , 2018, Front. Nutr..

[6]  J. R. Wagner,et al.  Emulsification Increases the Acute Ketogenic Effect and Bioavailability of Medium-Chain Triglycerides in Humans , 2017, Current developments in nutrition.

[7]  S. Cunnane,et al.  Butyrate is more ketogenic than leucine or octanoate-monoacylglycerol in healthy adult humans , 2017 .

[8]  D. Boison New insights into the mechanisms of the ketogenic diet , 2017, Current opinion in neurology.

[9]  S. Cunnane,et al.  Tricaprylin Alone Increases Plasma Ketone Response More Than Coconut Oil or Other Medium-Chain Triglycerides: An Acute Crossover Study in Healthy Adults , 2017, Current developments in nutrition.

[10]  L. Wojtczak,et al.  Short- and medium-chain fatty acids in energy metabolism: the cellular perspective , 2016, Journal of Lipid Research.

[11]  E. Croteau,et al.  Can ketones compensate for deteriorating brain glucose uptake during aging? Implications for the risk and treatment of Alzheimer's disease , 2016, Annals of the New York Academy of Sciences.

[12]  Gregory Lefebvre,et al.  Medium‐chain fatty acids inhibit mitochondrial metabolism in astrocytes promoting astrocyte‐neuron lactate and ketone body shuttle systems , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  M. Walker,et al.  Seizure control by decanoic acid through direct AMPA receptor inhibition , 2015, Brain : a journal of neurology.

[14]  S. Cunnane,et al.  Ketogenic response to cotreatment with bezafibrate and medium chain triacylglycerols in healthy humans. , 2015, Nutrition.

[15]  R. Veech Ketone ester effects on metabolism and transcription , 2014, Journal of Lipid Research.

[16]  J. Palmblad,et al.  Transfer of omega‐3 fatty acids across the blood–brain barrier after dietary supplementation with a docosahexaenoic acid‐rich omega‐3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study , 2014, Journal of internal medicine.

[17]  S. Cunnane,et al.  Stimulation of mild, sustained ketonemia by medium-chain triacylglycerols in healthy humans: estimated potential contribution to brain energy metabolism. , 2013, Nutrition.

[18]  D. Clegg,et al.  Dietary ketosis enhances memory in mild cognitive impairment , 2012, Neurobiology of Aging.

[19]  S. Henderson Ketone bodies as a therapeutic for Alzheimer’s disease , 2008, Neurotherapeutics.

[20]  L. Costantini,et al.  Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial , 2009, Nutrition & metabolism.

[21]  A. Williamson,et al.  Medium-Chain Fatty Acids Improve Cognitive Function in Intensively Treated Type 1 Diabetic Patients and Support In Vitro Synaptic Transmission During Acute Hypoglycemia , 2009, Diabetes.

[22]  K. Bateman,et al.  Rapid measurement of deuterium-labeled long-chain fatty acids in plasma by HPLC-ESI-MS Published, JLR Papers in Press, October 4, 2006. , 2007, Journal of Lipid Research.

[23]  M. Reger,et al.  Effects of β-hydroxybutyrate on cognition in memory-impaired adults , 2004, Neurobiology of Aging.

[24]  John J. Peterson,et al.  Estimation of Confidence Intervals for Area Under the Curve from Destructively Obtained Pharmacokinetic Data , 1998, Journal of Pharmacokinetics and Biopharmaceutics.

[25]  S. Cunnane,et al.  Breath acetone is a reliable indicator of ketosis in adults consuming ketogenic meals. , 2002, The American journal of clinical nutrition.

[26]  P. J. Jones,et al.  Medium chain fatty acid metabolism and energy expenditure: obesity treatment implications. , 1998, Life sciences.

[27]  P. Cryer,et al.  Effect of Hyperketonemia and Hyperlacticacidemia on Symptoms, Cognitive Dysfunction, and Counterregulatory Hormone Responses During Hypoglycemia in Normal Humans , 1994, Diabetes.

[28]  S. Amiel,et al.  Ketone infusion lowers hormonal responses to hypoglycaemia: evidence for acute cerebral utilization of a non-glucose fuel. , 1991, Clinical science.

[29]  S. Welle,et al.  Thermic effect of medium-chain and long-chain triglycerides in man. , 1986, The American journal of clinical nutrition.

[30]  K. Johnson An Update. , 1984, Journal of food protection.

[31]  A. Bach,et al.  Medium-chain triglycerides: an update. , 1982, The American journal of clinical nutrition.

[32]  A. Brickman,et al.  Resistance to symptomatic insulin reactions after fasting. , 1972, The Journal of clinical investigation.

[33]  J. Schrezenmeir,et al.  Medium chain Triglycerides , 1969, Drug and therapeutics bulletin.

[34]  G F Cahill,et al.  Brain metabolism during fasting. , 1967, The Journal of clinical investigation.